The National Institutes of Health StrokeNet

If your hospital is not in here for participating in stroke research ask why the hell not. Call the president. Don't care about keeping up with the latest research? Don't care about helping survivors recover? Just don't care?  Not my job?
http://stroke.ahajournals.org/content/47/2/301.extract?etoc

A User’s Guide

1. Joseph P. Broderick, MD;
2. Yuko Y. Palesch, PhD;
3. L. Scott Janis, PhD,
4. for the National Institutes of Health StrokeNet Investigators

+ Author Affiliations

1. From the Departments of Neurology and Rehabilitation Medicine and Radiology, University of Cincinnati Neuroscience Institute, University of Cincinnati Academic Health Center, OH (J.P.B.); Department of Public Health Sciences, Medical University of South Carolina, Charleston (Y.Y.P); and the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (L.S.J.).

1. Correspondence to Joseph P. Broderick, MD, Department of Neurology and Rehabilitation Medicine, University of Cincinnati Neuroscience Institute, 260 Stetson St, Suite 2300, PO Box 670525, Cincinnati, OH, 45267. E-mail joseph.broderick@uc.edu

Key Words:

• Editorials
• National Institute of Neurological Disorders and Stroke
• stroke
• United States

See related article, p 304.

The National Institute of Neurological Disorders and Stroke (NINDS) established the National Institutes of Health (NIH) StrokeNet to facilitate the rapid initiation and efficient implementation of small and large multisite exploratory and confirmatory clinical trials focused on promising interventions for stroke prevention, treatment, and recovery, as well as validation studies of biomarkers or outcome measures. The network is open to execute high-effect trial ideas that can come from any corner of the wide stroke community. This network, which was initiated in the Fall of 2013, currently involves 288 hospitals across the United States and is designed to serve as the infrastructure and pipeline for new potential treatments for patients with stroke and those at risk of stroke. NIH StrokeNet also provides a tremendous educational platform for stroke physicians and other healthcare professionals, particularly those individuals in training and focused on an academic career. To maximize the effect of NIH StrokeNet, it is important for the larger stroke community to know its structure and the process and timeline by which stroke trials are developed and implemented. For more detailed information on the NIH StrokeNet, its ongoing trials, and educational webinars, one can visit the website https://www.nihstrokenet.org/.